MIH
AZN icon

Meitav Investment House’s AstraZeneca AZN Stock Holding History

Meitav Investment House’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,020
Closed -$1.84M – 237
2025
Q4 		$1.84M Sell
10,020
-500
-5% -$87.7K 0.02% 142
2025
Q3 		$1.61M Sell
10,520
-73
-0.7% -$11K 0.02% 141
2025
Q2 		$1.48M Sell
10,593
-6,042
-36% -$847K 0.02% 132
2025
Q1 		$2.45M Sell
16,635
-102,500
-86% -$14.8M 0.05% 105
2024
Q4 		$15.6M Buy
119,135
+102,500
+616% +$14.3M 0.26% 74
2024
Q3 		$2.59M Sell
16,635
-6,062
-27% -$979K 0.04% 107
2024
Q2 		$3.54M Hold
22,697
– – 0.06% 102
2024
Q1 		$3.08M Hold
22,697
– – 0.06% 97
2023
Q4 		$3.06M Sell
22,697
-15,341
-40% -$1.99M 0.04% 135
2023
Q3 		$5.16M Sell
38,038
-495
-1% -$67.6K 0.08% 121
2023
Q2 		$5.49M Hold
38,533
– – 0.09% 125
2023
Q1 		$5.68M Sell
38,533
-3,905
-9% -$525K 0.1% 139
2022
Q4 		$5.77M Sell
42,438
-150
-0.4% -$18.8K 0.1% 144
2022
Q3 		$4.68M Sell
42,588
-9,574
-18% -$1.21M 0.08% 146
2022
Q2 		$6.89M Sell
52,162
-307
-0.6% -$40.3K 0.12% 124
2022
Q1 		$6.96M Buy
52,469
+19,411
+59% +$2.33M 0.1% 142
2021
Q4 		$3.86M Hold
33,058
– – 0.06% 173
2021
Q3 		$3.97M Buy
33,058
+1,358
+4% +$158K 0.07% 174
2021
Q2 		$3.8M Sell
31,700
-50
-0.2% -$5.49K 0.1% 138
2021
Q1 		$3.16M Buy
31,750
+26,205
+473% +$2.63M 0.09% 140
2020
Q4 		$556K Buy
+5,545
New +$587K 0.02% 265
2019
Q3 		– Sell
-3,000
Closed -$246K – 444
2019
Q2 		$246K Sell
3,000
-1,000
-25% -$78.4K 0.02% 367
2019
Q1 		$344K Sell
4,000
-1,000
-20% -$78.8K 0.02% 294
2018
Q4 		$373K Hold
5,000
– – 0.02% 227
2018
Q3 		$398K Hold
5,000
– – 0.02% 359
2018
Q2 		$349K Hold
5,000
– – 0.02% 360
2018
Q1 		$350K Buy
+5,000
New +$346K 0.02% 277

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Asset Management
Vanguard Asset Management London, Ec4n 8af $148B AUM

Meitav Investment House's AZN Position: Q1 2026 in Review

Meitav Investment House sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 10,020 shares — an estimated $1.84M sold.

Meitav Investment House first reported a position in AZN in Q1 2018 and held it in 27 quarters. The position peaked at $15.6M in Q4 2024. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Meitav Investment House reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Meitav Investment House sold 10,020 AstraZeneca shares in Q1 2026, an estimated $1.84M.
  • Meitav Investment House first reported a position in AstraZeneca in Q1 2018 and held it in 27 quarters.
  • Meitav Investment House's AstraZeneca position peaked at $15.6M in Q4 2024.
  • 1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Meitav Investment House's 13F filing for Q1 2026, filed 29 Apr 2026.